Fresh news on health and wellness in Sweden

Provided by AGP

AGP Executive Report

Last update: 10 hours ago

Dementia Diet Clues: A new 7-year study of 6,200+ Americans links five nutrients to lower dementia risk—isorhamnetin, dietary fiber, beta-tocopherol, beta-tocotrienol, and manganese—though it’s observational, not proof. Work-Life Health: Research presented in Europe finds cutting annual working hours by 1% is tied to a 0.16% drop in obesity rates across 33 OECD countries, with long hours pushing people toward worse food and less activity. Hantavirus Update: The MV Hondius cruise outbreak remains tightly managed; WHO says there’s no sign of a larger outbreak, while individual cases and quarantines continue to be tracked. Sweden Research Boost: Karolinska Institutet formalized a long-running partnership with INAB to expand cancer research, education, and “living labs” with patients. Diabetes Data Move: Glooko and mylife Diabetes Care expand their partnership so mylife products keep using Glooko as the primary data management platform. Cancer Pipeline at EHA: Multiple hematology updates are heading to EHA 2026 in Stockholm, including new abstracts on sickle cell and acute leukemia therapies.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.

YouTube video thumbnail: Trust the Source. Trust the News.
Play

Video Title


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
San Francisco's Outdoor Smoking Ban Won't Improve Public Health, but It Will Hurt the City's Bars and Taverns

San Francisco's Outdoor Smoking Ban Won't Improve Public Health, but It Will Hurt the City's Bars and Taverns

Community invited to a conversation on Youth Mental Health in South Snohomish County

Community invited to a conversation on Youth Mental Health in South Snohomish County

Swedish authorities say hantavirus outbreak from cruise ship not a pandemic risk

Swedish authorities say hantavirus outbreak from cruise ship not a pandemic risk

Hantavirus Outbreak: European Center for Disease Prevention and Control Says “Current Risk to the General Population Remains Very Low”

Hantavirus Outbreak: European Center for Disease Prevention and Control Says “Current Risk to the General Population Remains Very Low”


Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
4 hours ago

Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress

GlobeNewswire, Inc.

Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
14 hours ago

Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

GlobeNewswire, Inc.

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
17 hours ago

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

GlobeNewswire, Inc.

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
17 hours ago

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress

GlobeNewswire, Inc.

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress
17 hours ago

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

GlobeNewswire, Inc.

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress
17 hours ago

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Swedish FM Slams Putin: "Russia Is Not Interested in Peace"
Play
Swedish FM Slams Putin: "Russia Is Not Interested in Peace"
YouTube video thumbnail: Swedish FM Says Focus Should Be on Sanctions, Not Talks With Moscow
Play
Swedish FM Says Focus Should Be on Sanctions, Not Talks With Moscow
Discover Affinity Group Publishing
YouTube video thumbnail: 'Macron Always Been a Strong Believer in the Importance of Africa as a Partner for the Future'
Play
'Macron Always Been a Strong Believer in the Importance of Africa as a Partner for the Future'
YouTube video thumbnail: Iran Warns Europe Against Sending Warships to Hormuz as US Talks Gap Widens
Play
Iran Warns Europe Against Sending Warships to Hormuz as US Talks Gap Widens

Video Title

Sign up for:

Swedish Health Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share us

on your social networks:

Sign up for:

Swedish Health Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.